Gene · 5300
Papers3,752
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 3,752
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetic Peripheral Biomarkers for Early Diagnosis of Alzheimer's Disease. | Genes (Basel) | 2022 | 35893045 | PubTator, text mining | PubMed |
| Oxidative Stress in Tauopathies: From Cause to Therapy. | Antioxidants (Basel) | 2022 | 35892623 | PubTator, text mining | PubMed |
| Emerging Pathophysiological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: An Old Wine in a New Bottle. | J Alzheimers Dis Rep | 2022 | 35891636 | PubTator, text mining | PubMed |
| Phytochemicals as Regulators of Tumor Glycolysis and Hypoxia Signaling Pathways: Evidence from In Vitro Studies. | Pharmaceuticals (Basel) | 2022 | 35890106 | PubTator, text mining | PubMed |
| The Wako-Saitô-Muñoz-Eaton Model for Predicting Protein Folding and Dynamics. | Molecules | 2022 | 35889332 | PubTator, text mining | PubMed |
| A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health. | Molecules | 2022 | 35889273 | PubTator, text mining | PubMed |
| The Molten Globule State of a Globular Protein in a Cell Is More or Less Frequent Case Rather than an Exception. | Molecules | 2022 | 35889244 | PubTator, text mining | PubMed |
| Cancer-Associated Dysregulation of Sumo Regulators: Proteases and Ligases. | Int J Mol Sci | 2022 | 35887358 | PubTator, text mining | PubMed |
| Network Proximity-Based Drug Repurposing Strategy for Early and Late Stages of Primary Biliary Cholangitis. | Biomedicines | 2022 | 35884999 | PubTator, text mining | PubMed |
| Emerging role of anti-proliferative protein BTG1 and BTG2. | BMB Rep | 2022 | 35880434 | PubTator, text mining | PubMed |
| Pancreatic tumor eradication via selective Pin1 inhibition in cancer-associated fibroblasts and T lymphocytes engagement. | Nat Commun | 2022 | 35879297 | PubTator, text mining | PubMed |
| A Molecular Insight of the Role of PIN-1 Promoter Polymorphism (- 667C > T; rs2233679) in Chronic Kidney Disease Patients with Secondary Hyperparathyroidism. | Indian J Clin Biochem | 2022 | 35873609 | PubTator, text mining | PubMed |
Selection signature analyses and genome-wide association reveal genomic hotspot regions that reflect differences between breeds of horse with contrasting risk of degenerative suspensory ligament desmitis. | G3 (Bethesda) | 2022 | 35866615 | PubTator, text mining | PubMed |
| Chromatin Ubiquitination Guides DNA Double Strand Break Signaling and Repair. | Front Cell Dev Biol | 2022 | 35865631 | PubTator, text mining | PubMed |
| Comprehensive profiling and characterization of cellular microRNAs in response to coxsackievirus A10 infection in bronchial epithelial cells. | Virol J | 2022 | 35864512 | PubTator, text mining | PubMed |
| Proton TOCSY NMR relaxation rates quantitate protein side chain mobility in the Pin1 WW domain. | J Biomol NMR | 2022 | 35864369 | PubTator, text mining | PubMed |
| ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations. | RNA | 2022 | 35863867 | PubTator, text mining | PubMed |
| FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma. | Front Oncol | 2022 | 35847937 | PubTator, text mining | PubMed |
| Circular RNA circACAP2 Suppresses Ferroptosis of Cervical Cancer during Malignant Progression by miR-193a-5p/GPX4. | J Oncol | 2022 | 35847361 | PubTator, text mining | PubMed |
| E2F2 promotes lung adenocarcinoma progression through B-Myb- and FOXM1-facilitated core transcription regulatory circuitry. | Int J Biol Sci | 2022 | 35844795 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5300/papers?page=33